Answers are grounded in this paper and cite their sources.
Systematic review shows selective digestive decontamination reduces pneumonia and anastomotic leakage in esophagectomy patients, suggesting improved outcomes.
Background Esophagectomy is a complex surgical procedure with high morbidity and mortality mainly caused by postoperative infectious complications such as pneumonia and anastomotic leakage. Selective digestive decontamination (SDD) is a perioperative prophylactic non-absorbable antimicrobial strategy aimed to reduce postoperative infectious complications potentially lowering the density of pathogenic organisms in the oropharynx and esophagus. SDD has shown benefits in reducing infectious complications in intensive care units and lower gastrointestinal surgery. However, its efficacy and safety in patients undergoing esophagectomy is unclear, prompting this study to evaluate its perioperative use in these patients. Methods A systematic review and meta-analysis was conducted, including all study types regardless of design, by searching PubMed, Cochrane, Embase and Web of Science for publications up to October 2024. The primary outcome was efficacy, measured by the incidence of pneumonia, anastomotic leakage (AL), surgical site infection (SSI) and mortality. The secondary outcome was safety, measured by the occurrence of side effects and adverse events. The Cochrane risk of bias assessment tool and Newcastle-Ottawa quality assessment scale were used to assess risk of bias. Results Out of 616 articles screened, a total of 7 studies were included, with 487 patients in the SDD and 587 patients in the control group. SDD significantly reduced the incidence of pneumonia (odds ratio (OR) 0.42, 95% confidence interval (CI): 0.3–0.58, P < 0.01), anastomotic leakage (OR 0.43, 95% CI: 0.29–0.65, P < 0.01) and 30-day mortality (OR 0.25, 95% CI: 0.07 to 0.94; P = 0.04). No statistically significant difference was found regarding SSI (P = 0.20) and in hospital mortality (P = 0.28). Adverse events were scarcely reported, and those reported were mild, including an unpleasant taste and smell, sporadically resulting in nausea or vomiting. Conclusion This systematic review and meta-analysis, although composed of a limited number of studies, demonstrates that perioperative SDD reduces the risk of pneumonia, anastomotic leakage, and 30-day mortality following esophagectomy. Safety did not appear to be an issue, as the reported incidence of adverse events was minimal. However, none of the studies has provided systematic documentation of adverse events. Therefore, the evidence for SDD remains limited, highlighting the need for a large multicenter randomized controlled trial. To address this, the PERSuaDER trial is currently being conducted across Belgian and Dutch hospitals.
No takes yet. Share an insight, caveat, or question.
Grootenhuis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: